These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk of venous thrombosis with hormone-replacement therapy. Vandenbroucke JP; Helmerhorst FM Lancet; 1996 Oct; 348(9033):972. PubMed ID: 8855846 [No Abstract] [Full Text] [Related]
3. Type of hormone replacement therapy and risk of venous thromboembolism. Roberts H BMJ; 2008 May; 336(7655):1203-4. PubMed ID: 18495630 [TBL] [Abstract][Full Text] [Related]
4. Estrogen and the risk of coagulopathy. Lobo RA Am J Med; 1992 Mar; 92(3):283-5. PubMed ID: 1546727 [No Abstract] [Full Text] [Related]
6. [Hormone therapy and risk for venous thromboembolism in postmenopausal women]. Lacut K; Oger E Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617 [TBL] [Abstract][Full Text] [Related]
7. Hormone therapy and risk of venous thromboembolism among postmenopausal women. Canonico M; Scarabin PY Climacteric; 2009; 12 Suppl 1():76-80. PubMed ID: 19811247 [TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and thrombotic risk: beauty is only skin deep. Rosendaal FR Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):684-5. PubMed ID: 18797429 [TBL] [Abstract][Full Text] [Related]
9. Patch instead of pill: a safer menopausal estrogen? Cushman M Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):136-7. PubMed ID: 20089948 [No Abstract] [Full Text] [Related]
10. Case-control study of venous thromboembolism risk in users of hormone replacement therapy. Daly E; Vessey MP; Painter R; Hawkins MM Lancet; 1996 Oct; 348(9033):1027. PubMed ID: 8855869 [No Abstract] [Full Text] [Related]
11. Hormone replacement therapy is not a risk for venous thrombosis. Forbes CD; Greer IA Scott Med J; 1994 Dec; 39(6):165-6. PubMed ID: 8778977 [No Abstract] [Full Text] [Related]
12. Estrogen and progestogen effect on venous thromboembolism in menopausal women. Archer DF; Oger E Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609 [TBL] [Abstract][Full Text] [Related]
13. [Hormone therapy and risk of venous thromboembolism: new insights from the ESTHER study]. Canonico M; Scarabin PY Med Sci (Paris); 2008 Mar; 24(3):228-31. PubMed ID: 18334161 [No Abstract] [Full Text] [Related]
14. Lung cancer and hormone replacement therapy. Barton M; Meyer MR; Bolton JL; Prossnitz ER Lancet; 2010 Jan; 375(9709):117-8; author reply 118-9. PubMed ID: 20109881 [No Abstract] [Full Text] [Related]
17. Estradiol associated with lower thrombotic risk than conjugated equine estrogens when used as oral HRT. Brown S Menopause Int; 2013 Dec; 19(4):145. PubMed ID: 24479171 [No Abstract] [Full Text] [Related]
18. Transdermal hormone therapy and the risk of stroke and venous thrombosis. Speroff L Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199 [TBL] [Abstract][Full Text] [Related]
19. Further evidence for promoting transdermal estrogens in the management of postmenopausal symptoms. Canonico M; Scarabin PY Menopause; 2011 Oct; 18(10):1038-9. PubMed ID: 21946050 [No Abstract] [Full Text] [Related]
20. Transdermal and vaginal estradiol for the treatment of menopausal symptoms: the nuts and bolts. Kaunitz AM Menopause; 2012 Jun; 19(6):602-3. PubMed ID: 22549171 [No Abstract] [Full Text] [Related] [Next] [New Search]